Acute allergic reaction research hub

A phase IV, open, non-randomised, low-intervention clinical trial to evaluate the subjective user experience of Zeqmelit™ 6 mg mouth dissolving film for treatment of acute allergic reaction

This study is looking at how people feel about using Zeqmelit™ 6 mg mouth film to treat sudden allergic reactions. It's an open study, meaning everyone knows what treatment they're getting. We want to know if people are happy with it and feel safe when using this new film.